Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03644433
Other study ID # B.30.2.ATA.0.01.00/4
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 23, 2018
Est. completion date April 30, 2019

Study information

Verified date August 2018
Source Ataturk University
Contact Rasit Özler, Md
Phone 00905465252595
Email m.rasitozler@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We compares two techniques of uterine closure on myometrium thickness at the site of uterine scar of women who underwent repeated cesarean section. We will evaluate myometrial thickness by transvaginal ultrasound six months after cesarean.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date April 30, 2019
Est. primary completion date April 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- previous two or three cesarean

- gestational weeks >=36 weeks

Exclusion Criteria:

- risk of obstetric haemorrhage

- suspicion or diagnosis placenta previa or accrete syndrome

- chorioamnionitis

- uterine myoma in the anterior uterine segment

- hysterotomy other than lower segment uterine incision at previous cesarean

Study Design


Intervention

Procedure:
Single layer closure
Uterine incision will be approximated with continuous unlocked suture avoiding the inclusion endometrium and without trimming incision edges.
Double layer closure after resection uterine scar
Uterine incision will be trimmed and old scar tissue will be removed. Then first, endometrium will be approximated by continuous unlocked suture mimicking subcuticular suture avoiding the inclusion of endometrium and second, upper part of myometrium will be approximated by a continuous unlocked suture.

Locations

Country Name City State
Turkey Atatürk Üniversitesi arastirma Hastanesi Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary residual myometrial thickness Myometrial thickness at the uterine scar by transvaginal ultrasound 6 months after cesarean
Secondary residual myometrial thickness Myometrial thickness at the uterine scar by transvaginal ultrasound 6 weeks after cesarean
Secondary Healing ratio residual myometrial thickness * 100 /total myometrial thickness above uterine scar 6 months after cesarean
Secondary Healing ratio residual myometrial thickness * 100 /total myometrial thickness above uterine scar 6 weeks after cesarean
Secondary Existence of cesarean scar defect The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm. 6 months after cesarean
Secondary Existence of cesarean scar defect The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm. 6 weeks after cesarean
Secondary Operation time skin-to-skin operation time 10 minute after cesarean completed
Secondary Change in hemoglobin Difference in haemoglobin measured preoperatively and postoperatively 48 hours 48 hours after cesarean
Secondary Blood product transfusion unite number of transfused packed erythrocyte One week after cesarean
Secondary Maternal infectious morbidity prevalence of postpartum endometritis, skin wound dehiscence and post operative fever. six weeks after cesarean
Secondary Length of hospitalization Duration in days One month after cesarean
See also
  Status Clinical Trial Phase
Terminated NCT04377984 - Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
Recruiting NCT03248817 - Phenylephrine Infusion in Cesarean Delivery Phase 4
Completed NCT05037383 - Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions N/A
Completed NCT05933993 - Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
Recruiting NCT05021315 - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection Phase 3
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Completed NCT06403215 - Effect of Chewing Gum and Drinking Fennel Tea N/A
Not yet recruiting NCT06446258 - Assessment of the Impact of Soft Tissue Mobilization on the Scar in Patients After Cesarean Section N/A
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Not yet recruiting NCT06017076 - Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery. N/A
Completed NCT05005871 - Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain N/A
Recruiting NCT04518176 - Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins N/A
Not yet recruiting NCT04505644 - Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section N/A
Not yet recruiting NCT03985618 - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity N/A
Completed NCT04046510 - Comparaison of 3 Protocols of Ocytocin Administration in C Section N/A
Completed NCT03302039 - Three Protocols for Phenylephrine Administration in Cesarean Delivery Phase 4
Completed NCT03318536 - Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Recruiting NCT03682510 - B-Lynch Transverse Compression Suture Versus a Sandwich Technique (N&H Technique) for Complete Placenta Previa N/A
Recruiting NCT03651076 - Traxi Panniculus Retractor for Cesarean Delivery N/A
Not yet recruiting NCT06060327 - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section N/A